Bourla on Pfizer’s Experimental Drug to Treat COVID-19
NEW YORK – Pfizer Chairman and CEO Dr. Albert Bourla told CNBC on April 27 about his company’s “experimental oral drug to treat COVID-19 at the first sign of illness” which “could be available by the end of the year.”
